Back

MedAll, Partners for Advancing Clinical Education

  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

Evolving Paradigms in Lung Cancer: Module 3 Clinical Evidence for Bispecifics

Join Dr. Edward Garon as he explores the evolving role of precision medicine in non-small cell lung cancer (NSCLC). This expert-led microlearning module examines the biomarkers that guide treatment selection, from actionable genomic alterations to immunotherapy biomarkers such as PD-L1 expression and tumor mutational burden, while highlighting emerging molecular markers that may further refine personalized treatment strategies.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.25 creditsAAPA Category 1 Credit™Up to 0.25 creditsAMA PRA Category 1 Credit™Up to 0.25 creditsNursingUp to 0.25 creditsPharmacyUp to 0.25 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Microlearning
  • includes Online course / module
  • Credit · Up to 0.25 credits
  • Commercial Support
  • Released
    Jul 22, 2026
  • Last day to claim credit
    Jul 15, 2027 9 months left